P.37 Very elderly NSCLC patients above 75 years: Response to chemotherapy and improvement in quality of life is achievable to the same extent as for younger patients during platinum-based doublet chemotherapy
Jakob B. Sørensen(University of Copenhagen), Anne Hildur Henriksen(Norwegian University of Science and Technology), Lene Bæksgaard
Cited by 0
Related Papers
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Differential Control of the Releasable Vesicle Pools by SNAP-25 Splice Variants and SNAP-23
|Cell|2003|369
Sequential N‐ to C‐terminal SNARE complex assembly drives priming and fusion of secretory vesicles
|The EMBO Journal|2006|310